Trial · NCT02364947
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in the Number of Heavy Drinking Days (HDDs) From Baseline at Week 12 | Week 12 | The number of HDDs is defined as the number of days per month \[days/month\] with alcohol consumption of \> 60 g for males and \> 40 g for females |
| Secondary | Change in the Number of Heavy Drinking Days (HDDs) From Baseline at Week 24 | Week 24 | |
| Secondary | Change in Total Alcohol Consumption (TAC) From Baseline at Week 12 | Week 12 | |
| Secondary | Change in Total Alcohol Consumption (TAC) From Baseline at Week 24 | Week 24 | |
| Secondary | Response Shift Drinking Risk Level (RSDRL) at Week 12 | Week 12 | Proportion of patients with a downward shift in drinking risk level of two categories or more |
| Secondary | Response Shift Drinking Risk Level (RSDRL) at Week 24 | Week 24 | Proportion of patients with a downward shift in drinking risk level of two categories or more |
| Secondary | Response Low Drinking Risk Level (RLDRL) at Week 12 | Week 12 | Proportion of patients with low or lower drinking risk level |
| Secondary | Response Low Drinking Risk Level (RLDRL) at Week 24 | Week 24 | Proportion of patients with low or lower drinking risk level |
| Secondary | 70% TAC Responder Rate at Week 12 | Week 12 | Proportion of patients with a 70% decrease in TAC |
| Secondary | 70% TAC Responder Rate at Week 24 | Week 24 | Proportion of patients with a 70% decrease in TAC |
| Secondary | HDD Responder Rate at Week 12 | Week 12 | Proportion of patients with ≤4 HDDs |
| Secondary | HDD Responder Rate at Week 24 | Week 24 | Proportion of patients with ≤4 HDDs |
| Secondary | Change in CGI-S From Baseline at Week 12 | Week 12 | The CGI-S scale was used by clinicians when assessing their global impression of a patient's current clinical condition. The investigator or subinvestigator used his/her clinical experience with this patient population to rate the severity of a subject's clinical condition on a 7-point scale ranging from 1 (Normal, not at all ill) to 7 (Among the most extremely ill patients). |
| Secondary | Change in CGI-S From Baseline at Week 24 | Week 24 | The CGI-S scale was used by clinicians when assessing their global impression of a patient's current clinical condition. The investigator or subinvestigator used his/her clinical experience with this patient population to rate the severity of a subject's clinical condition on a 7-point scale ranging from 1 (Normal, not at all ill) to 7 (Among the most extremely ill patients). |
| Secondary | Change in CGI-I From Baseline at Week 12 | Week 12 | The CGI-I scale is used to assess a patient's improvement (or worsening). The investigator or subinvestigator assesses a subject's condition relative to baseline on a 7-point scale ranging from 1 (Very much improved) to 7 (Very much worse). |
| Secondary | Change in CGI-I From Baseline at Week 24 | Week 24 | The CGI-I scale was used to assess a patient's improvement (or worsening). The investigator or subinvestigator assesses a subject's condition relative to baseline on a 7-point scale ranging from 1 (Very much improved) to 7 (Very much worse). |
| Secondary | Change in Logarithm Scale in Serum γ-glutamyltransferase From Baseline at Week 12 | Week 12 | All-patients-randomised set |
| Secondary | Change in Logarithm Scale in Serum γ-glutamyltransferase From Baseline at Week 24 | Week 24 | All-patients-randomised set |
| Secondary | Change in Logarithm Scale in Serum Alanine Aminotransferase From Baseline at Week 12 | Week 12 | All-patients-randomised set |
| Secondary | Change in Logarithm Scale in Serum Alanine Aminotransferase From Baseline at Week 24 | Week 24 | All-patients-randomised set |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02364947/registered